Condensed Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (984,790)	$ (236,871)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization	31,289	31,329
Impairment loss	340,231
Stock-based compensation	105,650	4,326
Gain on sale of equity method investment		(100,000)
Changes in operating assets and liabilities:
Prepaid Expenses	(1,985)	(5,498)
Accounts payable	111,951	(13,940)
Accounts payable, related parties	159,457	(123,320)
Net Cash Used in Operating Activities	(238,197)	(443,974)
Cash Flows from Investing Activities:
Proceeds from sale of equity method investment		100,000
Net Cash Used in Investing Activities		100,000
Cash Flows from Financing Activities:
Proceeds from exercise of warrants	50,000
Payment of deferred offering costs	(15,001)
Proceeds from sale of common stock		560,000
Net Cash Provided By Financing Activities	34,999	560,000
Net Increase (decrease) in Cash	(203,198)	216,026
Cash, Beginning of year	217,295	1,269
Cash, End of year	14,097	217,295
Supplementary Cash Flow Information
Cash paid for interest
Cash paid for taxes
Supplementary Non-Cash Flow Information
Deferred offering costs in accounts payable	$ 35,440